Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-19

Clinical Trial Update: Study of Bisoprolol (Nerkardou - Nerhadou International) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment in Egyptian Patients With Essential Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing bisoprolol oral dissolvable film in Egyptian patients with essential hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bisoprolol ODF (Nerkardou) (Bisoprolol)

Snippet

Sponsor: Genuine Research Center, Egypt | Conditions: Essential Hypertension | Phase 4 | Status: RECRUITING